Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
Author(s) -
Liu Zaoqu,
Guo Chunguang,
Li Jing,
Xu Hui,
Lu Taoyuan,
Wang Libo,
Liu Long,
Han Xinwei
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
ISSN - 2001-1326
DOI - 10.1002/ctm2.619
Subject(s) - chek2 , medicine , cancer , palb2 , oncology , cancer research , head and neck squamous cell carcinoma , synthetic lethality , lung cancer , breast cancer , rad51 , homologous recombination , mutation , head and neck cancer , germline mutation , gene , dna repair , genetics , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom